Create Free Account

By creating account you will get access to hot stocks & personalised emails

Respiri Ltd

Healthcare AU RSH

0.072AUD
-0.003(4.00%)

Last update at 2024-12-19T05:11:00Z

Day Range

0.070.07
LowHigh

52 Week Range

0.020.10
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap99.49M
  • Volume202136
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-7.04991M
  • Revenue TTM1.04M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.59M
  • Diluted EPS TTM-0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -5.77529M -6.62431M -11.04035M -7.26093M -7.46990M
Minority interest - - - - -
Net income -5.77529M -6.62431M -11.04035M -7.26093M -6.45815M
Selling general administrative 4.83M 3.77M 5.84M 5.91M 2.41M
Selling and marketing expenses 0.22M 0.92M 2.19M 0.78M 0.85M
Gross profit 0.00493M -0.00560M -0.99338M -0.99338M 1.03M
Reconciled depreciation 0.08M 0.08M 0.08M 0.01M 0.00463M
Ebit -5.76029M -7.07286M -12.16192M -9.46264M -8.48165M
Ebitda -5.68300M -6.99090M -12.08232M -9.45226M -8.47702M
Depreciation and amortization 0.08M 0.08M 0.08M 0.01M 0.00463M
Non operating income net other - - - - -
Operating income -5.76453M -6.63119M -11.09170M -9.46264M -8.48165M
Other operating expenses 6.29M 6.88M 9.90M 9.46M 8.48M
Interest expense 0.01M 0.45M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.02M 0.08M 0.05M 0.00527M 0.02M
Net interest income -0.01500M - - 0.00166M 0.00514M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.61M -0.44854M -1.12157M -0.00166M -1.01175M
Total revenue 0.07M 0.25M 0.27M 0.27M 1.03M
Total operating expenses 6.36M 7.07M 11.17M 9.46M 8.48M
Cost of revenue 0.07M 0.26M 1.26M 1.26M -
Total other income expense net 0.59M 0.45M 1.12M 2.20M 1.01M
Discontinued operations - - - - -
Net income from continuing ops -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Net income applicable to common shares -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 6.19M 3.18M 4.21M 9.11M 4.62M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.27M 1.42M 0.03M 0.11M 0.37M
Total liab 3.55M 2.35M 1.20M 1.54M 2.12M
Total stockholder equity 2.64M 0.83M 3.01M 7.57M 2.49M
Deferred long term liab - - - - -
Other current liab 1.38M 0.63M 0.60M 0.31M 0.10M
Common stock 140.55M 132.10M 128.84M 127.09M 113.69M
Capital stock - 132.10M 128.84M 127.09M 113.69M
Retained earnings -141.91792M -138.05254M -133.31255M -126.34628M -115.30594M
Other liab - - - - 0.13M
Good will - - - - -
Other assets 0.00000M - - 0.00000M 0.00006M
Cash 0.76M 0.15M 1.22M 7.97M 3.55M
Cash and equivalents - - - 7.97M -
Total current liabilities 3.43M 2.24M 1.20M 1.47M 2.00M
Current deferred revenue 0.05M 0.06M 0.00316M 0.00086M 0.26M
Net debt -0.64648M 0.00297M -1.14661M -7.83072M -2.65945M
Short term debt 0.06M 0.03M 0.07M 0.07M 0.76M
Short long term debt - - - - 0.72M
Short long term debt total 0.12M 0.15M 0.07M 0.14M 0.89M
Other stockholder equity - -0.00055M 7.48M -0.74412M 4.11M
Property plant equipment - 0.18M 0.08M 0.16M 0.19M
Total current assets 4.03M 3.00M 4.12M 8.95M 4.43M
Long term investments - - - - -
Net tangible assets - 0.83M 3.01M 7.57M 2.49M
Short term investments - 0.03M 0.03M 0.54M 0.05M
Net receivables 0.25M 0.05M 0.05M 0.14M 0.00820M
Long term debt - - 0.00000M - -
Inventory 2.75M 1.23M 2.65M 0.54M 0.31M
Accounts payable 1.94M 1.51M 0.52M 1.08M 0.87M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.01M 6.78M 7.48M 6.83M 4.11M
Additional paid in capital - - - - -
Common stock total equity - - - - 113.69M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.04M -0.17633M -0.08269M 0.50M 0.00006M
Deferred long term asset charges - - - - -
Non current assets total 2.16M 0.18M 0.08M 0.16M 0.19M
Capital lease obligations - 0.15M 0.07M 0.14M 0.18M
Long term debt total - 0.12M 0.00000M 0.07M 0.13M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.02180M -0.00227M -0.05425M -0.01286M -0.00318M
Change to liabilities 1.12M -0.50270M 0.16M -0.62567M 0.76M
Total cashflows from investing activities -0.02180M -0.00227M -0.05425M -0.01286M -0.00318M
Net borrowings 0.20M 0.20M -0.74452M -0.14681M 0.80M
Total cash from financing activities 3.46M 1.64M 11.79M 7.96M 4.33M
Change to operating activities -0.29606M 0.26M 0.23M -0.02555M -0.42306M
Net income -5.77529M -6.62431M -11.04035M -7.26093M -8.47459M
Change in cash -1.07111M -6.75592M 4.42M 3.25M -2.11177M
Begin period cash flow 1.22M 7.97M 3.55M 0.31M 2.42M
End period cash flow 0.15M 1.22M 7.97M 3.55M 0.31M
Total cash from operating activities -4.49019M -8.47758M -7.33910M -4.68796M -6.41132M
Issuance of capital stock 3.65M 1.67M 13.08M 8.53M 3.75M
Depreciation 0.08M 0.08M 0.08M 0.01M 0.00463M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - 11.79M 7.96M 0.15M
Change to inventory 0.03M -2.11407M -0.22783M -0.30922M -0.30922M
Change to account receivables 0.00306M 0.09M -0.05779M 0.15M -0.04281M
Sale purchase of stock -0.39133M -0.03307M -0.54735M -0.42538M -0.21800M
Other cashflows from financing activities 0.20M -0.00227M -0.05425M -0.01286M 1.09M
Change to netincome 0.35M 0.34M 3.51M 3.37M 1.76M
Capital expenditures 0.02M 0.00227M 0.05M 0.01M 0.00318M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.03M -2.02839M -0.28561M -0.15585M 1.03M
Stock based compensation 0.34M 0.42M 3.53M 3.27M -
Other non cash items 1.21M -1.93522M 3.62M 2.56M 8.47M
Free cash flow -4.51199M -8.47985M -7.39335M -4.70082M -6.41450M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RSH
Respiri Ltd		 -0.003 4.00% 0.07 - 0.93 95.80 37.23 215.94 -7.6264
COH
Cochlear Ltd		 -3.32 1.13% 291.11 53.50 45.87 8.50 10.43 8.47 32.70
PNV
Polynovo Ltd		 -0.11 5.19% 2.01 206.00 138.89 13.79 20.21 13.83 352.63
AVH
Avita Therapeutics Inc		 -0.2 5.13% 3.70 - - 9.07 28.09 5.79 -10.0538
EBR
Ebr Systems Inc CDR		 0.12 14.53% 0.98 - - - 6.51 - -3.6785

Reports Covered

Stock Research & News

View All

Profile

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.

Respiri Ltd

432 St Kilda Road, Melbourne, VIC, Australia, 3004

Key Executives

Name Title Year Born
Mr. Nicholas Smedley Exec. Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Exec. Director NA
Mr. George Vlachodimitropoulos Chief Technology Officer NA
Mr. Theo Antonopoulos Chief Commercial Officer NA
Mr. Andrew Metcalfe CPA Company Sec. NA
Prof. Noam Gavriely Medical & Scientific Advisor NA
Mr. Simon Godfrey Medical & Scientific Advisor NA
Mr. Philippe Ludekens Gen. Mang. of Commercial Operations NA
Mr. Nicholas Smedley Executive Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.